About Antiven
Antiven is a company based in United Kingdom founded in 2023. It operates as a B2B. Antiven offers products and services including Lyophilised Vaccine. Antiven operates in a competitive market with competitors including Biological E, Altimmune, Vaxart, Allergy Therapeutics and Medicago, among others.
- Headquarter United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Antiven Private Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antiven
Antiven offers a comprehensive portfolio of products and services, including Lyophilised Vaccine.
Thermostable polyvalent vaccine for treating snake bite envenomation in humans and animals.
Funding Insights of Antiven
Detailed funding history for Antiven
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Antiven
Investment portfolio details for Antiven
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Antiven
Detailed financials for Antiven
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Antiven Comparisons
Peer comparison for Antiven
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Antiven
Antiven operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Altimmune, Vaxart, Allergy Therapeutics and Medicago, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for treating multiple infectious diseases
|
|
| Locked | Locked | Locked |
Aluminum-free allergy vaccines and diagnostics are developed for treatment.
|
|
| Locked | Locked | Locked |
Developer of vaccines to treat pandemic and seasonal influenza
|
|
| Locked | Locked | Locked |
Cancer vaccines using immune redirection are developed.
|
Detailed competitors of Antiven
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Antiven
Complete news archive for Antiven
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antiven
Antiven was founded in 2023.
Antiven is headquartered in United Kingdom.
Antiven is a vaccine development company that utilizes biotechnology and proteomics to produce thermostable, polyvalent vaccines for snake bite envenomation. It focuses on saving lives, reducing poverty, and improving access to treatments in remote areas, including for livestock. The company conducts patented research and is registered in England, with leadership from experts trained internationally.
Antiven's top competitors include Biological E, Vaxart and Allergy Therapeutics.
Antiven offers Lyophilised Vaccine.